These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 14593380)

  • 1. [Clinical efficacy of myocardial cytoprotector trimetazidine in peri- and postmenopausal women with ischemic heart disease].
    Churshin AD; Pimenov LT
    Kardiologiia; 2003; 43(8):31-5. PubMed ID: 14593380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trimetazidine and the contractile response of dysfunctional myocardium in ischaemic cardiomyopathy.
    Belardinelli R
    Rev Port Cardiol; 2000 Nov; 19 Suppl 5():V35-9. PubMed ID: 11206102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical efficacy of combined therapy with enalapril + trimetazidine in patients with hypertension comorbid with ischemic heart disease and metabolic disturbances].
    Petelina TI; Gapon LI; Bakhmatova IuA; Zhevagina IA
    Ter Arkh; 2005; 77(8):19-23. PubMed ID: 16206600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correction of episodes of transitory myocardial ischemia with trimetazidine in patients with ischemic heart disease combined with type 2 diabetes mellitus].
    Petriĭ VV; Mikova NV; Makolkin VI
    Kardiologiia; 2007; 47(7):22-5. PubMed ID: 18260890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of trimetazidine on myocardial perfusion and left ventricular systolic function in type 2 diabetic patients with ischemic cardiomyopathy.
    Belardinelli R; Cianci G; Gigli M; Mazzanti M; Lacalaprice F
    J Cardiovasc Pharmacol; 2008 Jun; 51(6):611-5. PubMed ID: 18574390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antiischemic efficacy of trimetazidine in patients with ischemic heart disease, stable angina pectoris and disturbances of carbohydrate metabolism].
    Fedotkina IuA; Panchenko EP
    Kardiologiia; 2002; 42(2):28-33. PubMed ID: 12494204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and hemodynamic efficacy of selective beta-blocker bisoprolol and cytoprotector trimetazidine in the treatment of chronic cardiac failure in patients with ischemic heart disease].
    Fedorova TA; Il'ina IuV; Sotnikova TI; Rybakova MK; Loshchits NV
    Ter Arkh; 2004; 76(3):62-8. PubMed ID: 15108463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative efficacy of combined therapy with preductal and amino acid composition in elderly patients with coronary heart disease and class II-III angina].
    Zaslavskaia RM; Kelimberdieva ES; Komissarova IA; Teĭblium MM; Goncharov LF; Goncharova ZF; Akhmetov KZh
    Ter Arkh; 1999; 71(11):58-61. PubMed ID: 10626340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Potentialities of cytoprotection in the treatment of chronic heart failure in patients with coronary heart disease].
    Fedorova TA; Il'ina IuV; Sotnikova TI; Rybakova MK
    Klin Med (Mosk); 2004; 82(11):15-20. PubMed ID: 15656392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Decrease in the sensitivity to the anti-ischemic effect of propranolol and prospects for correcting it in patients with stable angina pectoris].
    Butina EK; Kokurina EV; Dmitrieva NA; Bochkareva EV
    Ter Arkh; 2002; 74(9):36-41. PubMed ID: 12418118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Assessment of antianginal and antiischemic effect of trimetazidine and its effects on myocardial perfusion in patients with ischemic heart disease and stable angina.].
    Orlova EM; Mironova IIu; Matveeva MA; Lupanov VP; Samoĭlenko LE; Naumov VG
    Kardiologiia; 2004; 44(9):23-8. PubMed ID: 15477771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of trimetazidine on quality of life in elderly patients with ischemic dilated cardiomyopathy.
    Marazzi G; Gebara O; Vitale C; Caminiti G; Wajngarten M; Volterrani M; Ramires JA; Rosano G; Fini M
    Adv Ther; 2009 Apr; 26(4):455-61. PubMed ID: 19396409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic management of ischemic heart disease: clinical data with trimetazidine.
    Desideri A; Celegon L
    Am J Cardiol; 1998 Sep; 82(5A):50K-53K. PubMed ID: 9737486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of long-term therapy with trimetazidine in patients with ischemic heart disease in combination with chronic obstructive pulmonary disease].
    Kolomoets NM; Baksheev VI; Zarubina EG; Uvaĭsova IU
    Kardiologiia; 2008; 48(2):47-51. PubMed ID: 18261009
    [No Abstract]   [Full Text] [Related]  

  • 15. The antiischemic effects and tolerability of trimetazidine in coronary diabetic patients. A substudy from TRIMPOL-1.
    Szwed H; Sadowski Z; Pachocki R; Domzał-Bocheńska M; Szymczak K; Szydłowski Z; Paradowski A; Gajos G; Kałuza G; Kulon I; Wator-Brzezińska A; Elikowski W; Kuźniak M
    Cardiovasc Drugs Ther; 1999 May; 13(3):217-22. PubMed ID: 10439884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of trimetazidine in management of ischemic cardiomyopathy.
    Bertomeu-Gonzalez V; Bouzas-Mosquera A; Kaski JC
    Am J Cardiol; 2006 Sep; 98(5A):19J-24J. PubMed ID: 16931202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy and tolerance of trimetazidine, a metabolic antianginal, in combination with a hemodynamic antianginal in stable exertion angina. TRIMPOL I, a multicenter study].
    Szwed H; Pachocki R; Domzal-Bochenska M; Szymczak K; Szydlowski Z; Paradowski A; Gajos G; Kaluza G; Kulon I; Wator-Brzezińska A; Elikowski W; Kuźniak M
    Presse Med; 2000 Mar; 29(10):533-8. PubMed ID: 10761517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trimetazidine in Practice: Review of the Clinical and Experimental Evidence.
    Dézsi CA
    Am J Ther; 2016; 23(3):e871-9. PubMed ID: 25756467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Trimetazidine in correction of chronic heart failure in patients with ischemic heart disease].
    Nedoshivin AO; Kutuzova AE; Nesterova IV; Mikhaĭlova IE; Rubashkina EI; Novikova NA; Liasnikova EA; Perepech NB
    Kardiologiia; 2002; 42(3):12-5. PubMed ID: 12494179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Enhancement of antioxidant status of the elderly patients with ischemic heart disease in response to amino acid composition of MP-33 in combined therapy with trimetazidine].
    Kalinina EB; Komissarova IA; Zaslavskaia RM; Zhdanov IuA
    Klin Med (Mosk); 2002; 80(5):50-3. PubMed ID: 12087889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.